APP Takes Angiomax Patent Extension Fight To Fed. Circ.
APP Pharmaceuticals LLC tried to convince the Federal Circuit on Tuesday that it has standing and can prove injury sufficient to challenge the extension of The Medicines Co.'s patent for its...To view the full article, register now.
Already a subscriber? Click here to view full article